About Erli Plus XR Tablet 25mg / 1000mg
Empagliflozin + metformin XR combo for type 2 diabetes blood sugar control.
Erli Plus XR Tablet 25mg / 1000mg Uses
- Controls high blood sugar in adults with type 2 diabetes
- Used when metformin alone does not achieve adequate glycaemic control
- Combines an SGLT2 inhibitor with extended release metformin in one tablet
- Reduces the number of daily pills needed for combination diabetes therapy
- Supports long-term blood sugar management alongside diet and exercise
Erli Plus XR Tablet 25mg / 1000mg Benefits
- Lowers HbA1c through two complementary mechanisms of action
- May support modest weight reduction compared to insulin secretagogues
- Extended release metformin component reduces gastrointestinal upset versus immediate release dosing
- Once-daily dosing improves adherence in patients on multiple medications
- Empagliflozin component offers additional cardiovascular and kidney protective effects in eligible patients
What Experts Say
Empagliflozin combined with extended release metformin targets two separate mechanisms in type 2 diabetes. Empagliflozin blocks renal glucose reabsorption via SGLT2 inhibition, while metformin XR reduces hepatic gluconeogenesis and improves peripheral insulin sensitivity over a slower absorption curve.
This dual action allows physicians to address both insulin resistance and excess renal glucose retention with one daily tablet, improving adherence compared to separate formulations. Clinicians favour the fixed-dose XR combination in patients already stable on metformin who need additional glycaemic control without adding a separate SGLT2 inhibitor pill.
Renal function monitoring guides dosing decisions, since metformin accumulation risk rises as eGFR falls and empagliflozin efficacy depends on adequate renal filtration. Physicians recommend periodic kidney function tests, especially in patients with long-standing diabetes, given Pakistan carries a high burden of undiagnosed chronic kidney disease alongside type 2 diabetes.
Drug Class
- SGLT2 Inhibitor and Biguanide Combination
- Antidiabetic Agent
Erli Plus XR Tablet 25mg / 1000mg Uses in Urdu
- ٹائپ 2 ذیابیطس میں بلڈ شوگر کو کنٹرول کرنے کے لیے استعمال ہوتی ہے
- جب اکیلی میٹفارمن سے شوگر کنٹرول نہ ہو تو تجویز کی جاتی ہے
- ایک ہی گولی میں دو مختلف طریقہ کار سے شوگر کم کرتی ہے
- روزانہ ایک بار لینے سے ادویات کی تعداد کم ہو جاتی ہے
- غذا اور ورزش کے ساتھ طویل مدتی شوگر کنٹرول میں مددگار ہے
Erli Plus XR Tablet 25mg / 1000mg formula
- Empagliflozin 25mg + Metformin 1000mg
How to use Erli Plus XR Tablet 25mg / 1000mg?
- Take the tablet once daily with the evening meal unless your doctor advises otherwise
- Swallow the tablet whole; do not crush, split, or chew the extended release formulation
- Take it at roughly the same time each day for consistent blood sugar control
- Do not skip doses even if you feel well, since diabetes control needs steady dosing
- Stay well hydrated, particularly in hot weather, to reduce dehydration risk from the SGLT2 component
- Continue prescribed diet and exercise changes alongside this medicine
- Inform your doctor before any surgery or contrast dye procedure, as the medicine may need temporary pausing
Drug Interactions
- Diuretics: Combined use can increase the risk of dehydration and low blood pressure.
- Insulin or Sulfonylureas: Raises the risk of hypoglycaemia when combined with this medicine.
- Iodinated Contrast Dye: Increases risk of acute kidney injury and lactic acidosis; metformin should be paused around the procedure.
- Alcohol: Excessive alcohol intake raises lactic acidosis risk and can affect blood sugar control.
- Diuretic and Blood Pressure Medicines: May compound the volume-depleting effect of the SGLT2 component.
Risks and warnings
- Lactic Acidosis: Metformin carries a rare but serious risk of lactic acidosis, especially with kidney impairment or dehydration.
- Genital Infections: Empagliflozin increases risk of fungal genital infections due to glucose in urine.
- Urinary Tract Infections: Increased urinary glucose can raise the chance of urinary tract infections.
- Dehydration and Low Blood Pressure: The diuretic-like effect of empagliflozin can cause volume depletion, particularly in elderly patients.
- Kidney Function: Regular monitoring is needed since both components depend on adequate renal clearance.
- Diabetic Ketoacidosis: Rare cases of ketoacidosis with near-normal blood sugar have been reported with SGLT2 inhibitors.
- Pregnancy and Breastfeeding: Not recommended; discuss safer alternatives with your doctor if pregnant or breastfeeding.
- Surgery and Imaging Procedures: Temporary discontinuation may be required before contrast imaging or major surgery.
Erli Plus XR Tablet 25mg / 1000mg Side Effects
- Nausea
- Diarrhoea
- Stomach discomfort
- Loss of appetite
- Genital yeast infection
- Urinary tract infection
- Increased urination
- Thirst
- Dizziness
- Low blood pressure
- Metallic taste
- Vitamin B12 deficiency with long-term use
Storage Conditions
- Store the tablet blister below 30°C in a cool, dry place
- Keep in the original pack away from direct sunlight and moisture
- Keep out of reach of children
- Do not store in the bathroom or near a kitchen sink
